Magan, N., Isaacs, RJ., & Stowell, KM. (2012). Treatment with the PARP-inhibitor PJ34 causes enhanced doxorubicin-mediated cell death in HeLa cells. Anti-Cancer Drugs. 23(6), 627-637 [Journal article]Authored by: Magan, N., Stowell, K.
Farley, PC., Magan, N., Charron, CL., Broomfield, NI., & Farley, AF. (2007). You be the examiner!: "Model answers" that require critical thinking. Biochemistry and Molecular Biology Education. 35(6), 392-396 [Journal article]Authored by: Magan, N.